Affordable Access

deepdyve-link
Publisher Website

The effect of a triple therapy on maternal anti-Ro/SS-A levels associated to fetal cardiac manifestations.

Authors
  • Martínez-Sánchez, Nuria
  • Robles-Marhuenda, Ángel
  • Álvarez-Doforno, Rita
  • Viejo, Aurora
  • Antolín-Alvarado, Eugenia
  • Deirós-Bronte, Lucía
  • Bartha, Jose Luis
Type
Published Article
Journal
Autoimmunity Reviews
Publisher
Elsevier
Publication Date
May 01, 2015
Volume
14
Issue
5
Pages
423–428
Identifiers
DOI: 10.1016/j.autrev.2015.01.005
PMID: 25599954
Source
Medline
Keywords
License
Unknown

Abstract

A triple therapy combining plasmapheresis, IVIG and glucocorticoids may stop the natural evolution of the fetal cardiac affectation in positive anti-Ro/SS-A antibody patients. Further studies are needed in order to validate clinical applications of this treatment approach.

Report this publication

Statistics

Seen <100 times